Predictors of completing a primary health care diabetes prevention intervention programme in people at high risk of type 2 diabetes : experiences of the DE-PLAN project by Gilis-Januszewska, Aleksandra et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/m
d-journalby
BhD
M
f5ePH
Kav1zEoum
1tQ
fN
4a+kJLhEZgbsIH
o4XM
i0hC
yw
C
X1AW
nYQ
p/IlQ
rH
D
3YR
R
6H
yw
xYO
M
R
tB4H
O
KvFY0R
n0FzER
D
jo+Q
9m
5e0281V2LKG
g1hD
d+g==
on
06/10/2020
Downloadedfromhttps://journals.lww.com/md-journalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3YRR6HywxYOMRtB4HOKvFY0Rn0FzERDjo+Q9m5e0281V2LKGg1hDd+g==on06/10/2020
Predictors of completing a primary health care
diabetes prevention intervention programme in
people at high risk of type 2 diabetes
Experiences of the DE-PLAN project
Aleksandra Gilis-Januszewska, MD, PhDa,
∗
, Jaana Lindström, MSc, PhDb, Noël C Barengo, MD, PhDc,
Jaakko Tuomilehto, MD, PhDd,e,f,g,h, Peter EH Schwarz, MD, PhDi,j,k, Ewa Wójtowicz, MScl,
Beata Piwonska-Solska, MD, PhDl, Zbigniew Szybinski, MD, PhDl, Adam Windak, MD, PhDm,
Alicja Hubalewska-Dydejczyk, MD, PhDl
Abstract
It has been shown that real-life implementation studies for the prevention of type 2 diabetes (DM2) performed in different settings and
populations can be effective. However, not enough information is available on factors influencing the reach of DM2 prevention
programmes. This study examines the predictors of completing an intervention programme targeted at people at high risk of DM2 in
Krakow, Poland as part of the DE-PLAN project.
A total of 262 middle-aged people, everyday patients of 9 general practitioners’ (GP) practices, at high risk of DM2 (Finnish
Diabetes Risk Score (FINDRISK)>14) agreed to participate in the lifestyle intervention to prevent DM2. Intervention consisted of 11
lifestyle counseling sessions, organized physical activity sessions followed by motivational phone calls and letters. Measurements
were performed at baseline and 1 year after the initiation of the intervention.
Seventy percent of the study participants enrolled completed the core curriculum (n=184), 22% were men. When compared to
noncompleters, completers had a healthier baseline diabetes risk profile (P<.05). People who completed the intervention were less
frequently employed versus noncompleters (P= .037), less often had hypertension (P= .043), and more frequently consumed
vegetables and fruit daily (P= .055).
In multiple logistic regressionmodel, employment reduced the likelihood of completing the intervention 2 times (odds ratio [OR] 0.45,
95% confidence interval [CI] 0.25–0.81). Higher glucose 2 hours after glucose load and hypertension were the independent factors
decreasing the chance to participate in the intervention (OR 0.79, 95% 0.69–0.92 and OR 0.52, 95%CI 0.27–0.99, respectively). Daily
consumption of vegetables and fruits increased the likelihood of completing the intervention (OR 1.86, 95% 1.01–3.41).
In conclusion, people with healthier behavior and risk profile are more predisposed to complete diabetes prevention interventions.
Male, those who work and those with a worse health profile, are less likely to participate and complete interventions. Targeted
strategies are needed in real-life diabetes prevention interventions to improve male participation and to reach those who are working
as well as people with a higher risk profile.
Abbreviations: BMI = body mass index, CVD = cardiovascular disease, DE-PLAN = Diabetes in Europe: Prevention Using
Lifestyle, Physical Activity and Nutritional Intervention, DM2 = type 2 diabetes, DPS = Diabetes Prevention Study, FINDRISK =
Finnish Diabetes Risk Score, GP= general practitioner, HIPS= the Health Improvement and Prevention Study, IFG= impaired fasting
glucose, IGT = impaired glucose tolerance, OGTT = oral glucose tolerance test, RCT = randomized controlled trial, Sydney DPP =
Sydney Diabetes Prevention Program.
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1. Introduction
The vivid increase of type 2 diabetes (DM2) prevalence and its
complications observed worldwide call for an intensified search
for strategies aimed at reducing the disease burden. Lifestyle
interventions through dietary and physical changes have proved
to be very effective in DM2 prevention and, as demonstrated in
several randomized controlled trials (RCTs), they reduce DM2
incidence up to 60%.[1–3] There are also very promising results of
real-life implementation studies performed in different settings
and populations, which have proved that less-intensive, lower
budget lifestyle interventions can also be effective and can result
in long-term beneficial outcomes.[4–16]
Nevertheless, there are still many challenges in the field of DM2
prevention. As the main focus is to achieve health benefits at the
population level, improvement of the reach and efficacy of the
programmes are one of the most important public health burdens.
Recruitment rates in RCTs are known to be very low, but this
highly controlled clinical situation cannot be compared with real-
life setting.[2] However, among randomized patients, completion
of the programme was high, which suggests that people
participating in RCTs are a very selective, highly motivated
group.[2] The data on participation rates and completion of
interventions in implementation studies are very scarce. Also, very
little is known about the factors affecting completion of
intervention and attendance. In some studies, age, education,
health, and economic status as well as the level of psychological
distress were related to the participation in the pro-
grammes.[6,7,11,17,18] There are also very important practical
external obstacles like work commitments, accessibility, afford-
ability, and practicality of the interventions, as well as factors
related to thequalityof interventionprovided,whichmay influence
the uptake of the prevention programmes.[17–19] The DE-PLAN
project (Diabetes in Europe: Prevention Using Lifestyle, Physical
Activity and Nutritional Intervention) was an EU-initiated and
sponsored real-life implementation study aiming to assess the
reach, adoption, and implementation of the programme in diverse
real-life settings in 17 countries in Europe, but also to create a
network of trained and experienced professionals to continue
DM2 prevention across Europe.[4,5,10,11,20]
The aim of this study was to investigate the predictors of
completing an intervention programme within primary health-
care targeted at people at high risk of DM2 in Krakow, Poland
within the framework of the DE-PLAN project.
2. Materials and methods
TheDE-PLANproject was based on the principles of the Diabetes
Prevention Study (DPS)[1] and examined the intervention
implementation in real-life settings and hence the design of the
study was not randomized.
A detailed description of the programme has been published
previously.[7,8] The study was performed in 9 independent
primary healthcare general practitioners’ (GP) practices in
Krakow and entailed city inhabitants aged >25 years who met
inclusion criterion of high diabetes risk assessed with the Finnish
Diabetes Risk Score (FINDRISK) >14) (33% chance of
developing DM2 within 10 years). Information about the study
and the leaflets with FINDRISK questionnaire were distributed in
co-operating practices. Patients with known risk factors were
directly approached by nurses and medical staff. Out of 800
FINDRISK questionnaires distributed, 566 were completed, 368
respondents scored FINDRISK >14 (Fig. 1)
Subsequently, 275 people signed informed consent and agreed
to undergo oral glucose tolerance test (OGTT) examination. Out
of these, 262 (258 with all measurements done) were invited to
participate in the intervention. A total 184 participants
completed the intervention (completers). Among completers,
the number of completed counseling sessions was from 8 to 11 (9
participants completed all sessions but not the final examination
after 1 year). Around 74 of eligible participants who completed
all baseline examination and agreed to participate in the study did
not eventually participate in the intervention (noncompleters).
Among noncompleters, the number of completed counseling
sessions was from 0 to 3.
This study followed the Good Clinical Practice guidelines and
the guidelines of the Helsinki Declaration. The study protocol
was approved by the Jagiellonian University Ethics Committee.
The committee’s reference number is KBET/43/L/2006. All study
participants gave their written informed consent before the
participation in the study.
Two nurses in each of the participating practices have been
trained to act as diabetes prevention managers and deliver
intervention. The intervention consisted of reinforced behavior
modification with a special focus on the following lifestyle goals:
weight loss of initial body mass, reduced intake of total fat,
reduced intake of saturated fat, increased consumption of fiber
(from fruit, vegetables, and cereal), and increased physical
activity.[1,4,5,20]
The intervention lasted 10 months and consisted of 1
individual session and 10 group sessions (10–14 people) followed
by 6 motivational telephone calls and 2 motivational let-
ters.[1,4,5,20] From week 4 of the initiation of the intervention,
patients were offered free of charge physical activity sessions 2
times a week. In case of a patient’s cancellation or no-show for a
scheduled appointment, the staff called the patient to reschedule
and provide motivation to continue the study. In case of logistic
problems to continue counseling with the initial group, the
patient was offered participation in another group (with more
convenient location and timetable of sessions). In the course of
the intervention, 6 meetings were organized for prevention
managers to discuss the problems and share their experience, as
well as to allow them to consult any issues concerning physical
800 FINDRISC1 distributed
566 FINDRISC completed
368 168
FINDRISC > 14 FINDRISC ≤ 14
275 93
signed consent 
and agreed for OGTT2
not signed consent
262 13
invited to parcipate 
in the intervenon
newly screened 
DM23
258
completed baseline 
measurements
184 74
completed 
intervenon
not completed 
intervenon
1 Finnish Diabetes Risk Score, 2 Oral glucose tolerance test; 3 Diabetes mellitus type 2
Figure 1. The flow chart: study participants, completers, and noncompleters.
Gilis-Januszewska et al. Medicine (2018) 97:5 Medicine
2
activity, diet, and motivation techniques. In case of nonpartici-
pation, the nurses were asked to provide the reasons explaining
the patients’ decision. Prevention managers could also consult a
dietitian and physical activity specialist over the telephone.[4,5]
2.1. Measurements and predictors
The baseline examination procedure included: questionnaires
(FINDRISK, baseline, clinical, and lifestyle and quality of life)
and biochemical tests such as: fasting and 1200OGTT glucose,
serum triglycerides, high-density lipoprotein, and total choles-
terol. Impaired fasting glucose (IFG) was defined as fasting
plasma glucose concentration of 6.1 to 7.0mmol/L. Impaired
glucose tolerance (IGT) was defined as glucose plasma
concentration of 7.80 to 11.0mmol/L after oral administration
of 75g of glucose (OGTT). Diabetes mellitus was defined as
fasting glucose concentration of >7.0mmol/L or glucose
concentration of >11.1mmol/L at 2 hours of OGTT (1200
OGTT).[4,5] Body mass index (BMI) was calculated as weight (in
light indoor clothes, kg) divided by height squared (m2); waist
circumference was measured midway between the lowest rib and
iliac crest; diastolic and systolic blood pressures were taken while
sitting after 10-minute rest.
Data on education, marital status, employment status, history
of increased blood glucose, family history of diabetes, Finnish
Diabetes Risk Score (FINDRISK), smoking status, history of
hypertension, history of cardiovascular disease, and depression
were taken with the of self-reported questionnaire.
Lifestyle was explored with the use of simple self-reported
questions on physical activity and consumption of vegetables and
fruit. The following questions were asked: “Do you perform at
least 30 minutes of physical activity at work and/or during leisure
time (including normal daily activity each day)” or “Do you eat
fruit or vegetables daily?” Measurements were performed at
baseline and then repeated after 1 and after 3 years from the
initiation of the intervention.[5]
2.2. Statistical analyses
The descriptive analyses are given as percentages (for categorical
variables) and means with standard deviations (for continuous
variables). Chi-square tests for categorical variables and t tests for
continuous ones were applied to compare the distribution
between the potential predictors according to whether the
participants completed the intervention or not. Stepwise logistic
regression models were used to assess the association between the
different predictors and outcome variable. The odds ratios (ORs)
and the respective 95% confidence interval (CI) were calculated.
A P-value of<.05 was considered statistically significant.
The data were analyzed using STATISTICA version 12
(StatSoft, Inc, 2014, www.statsoft.com).
3. Results
Out of 368 respondents eligible to participate in the study
(FINDRISK > 14), 275 (75%) agreed to undergo OGTT
examination and subsequently 262 (71%) agreed to participate in
the study (258 with complete baseline examination). A total of 184
(70% of all who agreed) completed the core curriculum while 74
(30%ofallwhoagreed)didnot eventually complete the intervention.
Out of those who agreed to participate in the study, 24% were
men, while the percentage of men among completers was 22%
and among noncompleters was 30% (ns).
Baseline data of completers and noncompleters are presented
in Table 1. Noncompleters had higher 1200 OGTT glucose and
triglycerides (P= .046, P= .004) in comparison with completers.
IFG or IGT was more frequent among noncompleters versus
completers (36% vs 25%, P= .069). Those who did not complete
the intervention were more frequently employed versus com-
pleters (P= .037), more often had a family history of diabetes
(P= .066) and hypertension (P= .043). There were no differences
in education, marital status, smoking, and frequency of
depression between completers and noncompleters. As far as
lifestyle factors are concerned, completers more frequently
consumed vegetables and fruit every day versus noncompleters
(41% versus 30%, P= .055). There were no other baseline
differences between completers and noncompleters.
In multiple logistic regression model the status of being
employed decreased the likelihood of completing the intervention
2 times (OR 0.45, 95% CI 0.25–0.81). Patients with higher 1200
OGTT glucose and hypertension were found to have lower
completion rate (OR 0.79, 95%0.69–0.92 andOR 0.52, 95%CI
0.27–0.99, respectively). Daily consumption of vegetables and
fruits increased the likelihood of completing the intervention (OR
1.86, 95% CI 1.01–3.41) (Table 2). Thirty percent of non-
completers gave the reason of nonparticipation in the interven-
tion, the most commonly declared reasons were: “shortage of
time” and “inability to continue time-consuming programme,”
“working commitments,” and other commitments like “taking
care of children, grandchildren, or elderly parents.”
4. Discussion
Results of real-life implementation studies performed in different
settings and populations proved that lifestyle DM2 prevention
interventions, however less-intensive and less costly than RCTs,
can be effective, and that beneficial outcomes can last for a longer
time.[7–19] However, in order to achieve health benefits at
population level, the reach and efficacy of the programmes should
be improved. Therefore, the present study investigates the factors
influencing the completion of the DE-PLAN programme designed
as a real-life, real-setting, lifestyle DM2 prevention intervention.
In our study, 30% of those who completed all baseline
examinations and initially agreed to participate did not
eventually complete the intervention. Noncompleters had worse
health profile versus completers. People who did not complete the
intervention were more frequently employed as compared to
completers and more often had hypertension. Completers more
frequently consumed vegetables and fruit on a daily basis when
compared to noncompleters. Employment was an independent
noncompletion factor and it decreased the probability to
complete the intervention 2 times. Also, hypertension was an
independent factor decreasing the chance to complete the study 2
times, while daily consumption of vegetables and fruit was
increasing the chance to complete the study.
In the similar prevention study performed in occupational
setting in Finland, out of 657 people (airline employees) with
baseline increased DM2 risk invited to the intervention, 53%
agreed to participate.[6] Unlike in our study where only 22% of
participants were men, in Finland men and women attended the
intervention equally. FINDRISK score, waist circumference, BMI,
sedentary lifestyle, depression, sleeping problems, and stress
affecting work ability increased participation in both sexes.[6] In
another DE-PLAN study run in Greece, where patients were
recruited through primary healthcare centers and workplace, out
of 620 high-risk individuals, 191 agreed to participate in the study
Gilis-Januszewska et al. Medicine (2018) 97:5 www.md-journal.com
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and 125 fully completed the programme.[11] In this study, glucose
intolerance and the site of recruitment was independently
associated with participation in the programme.[11]
In the Sydney Diabetes Prevention Program (Sydney DPP),[18]
one-third of eligible patients did not participate in the programme
despite undergoing the initial screening process. In this study,
people with family history of diabetes and history of high blood
glucose, physically inactive were significantly more likely to
enroll in the study, while high-risk individuals who smoked, were
born in a high diabetes risk region, took blood pressure-lowering
Table 2
Multivariate analysis of predictors of completing† the lifestyle interventions programme in primary healthcare in Krakow, Poland.
Full model Reduced model
Variable OR 95% CI OR 95% CI
Age 0.99 0.95–1.03
Sex (man vs woman) 0.90 0.39–2.07
BMI, kg/m2 1.02 0.92–1.12
FINDRISK 0.95 0.81–1.12
WC 0.98 0.94–1.03
1200 OGTT 0.83 0.70–0.97 0.79 0.69–0.92
∗
TC 0.93 0.69–1.26
TG 0.89 0.73–1.09
Education (basic/medium vs high) 1.67 0.81–3.45
Employment (yes vs no) 0.45 0.21–0.96 0.45 0.25–0.81
∗∗
Family history of diabetes (yes vs no) 0.54 0.25–1.19
Current smoking (yes vs no) 0.66 0.32–1.36
History of hypertension (yes vs no) 0.63 0.29–1.34 0.52 0.27–0.99
∗∗∗
>30-minute daily physical activity (yes vs no) 0.88 0.37–2.07
Daily consumption of vegetable and fruit (yes vs no) 1.98 1.01–3.85 1.86 1.01–3.41
∗∗∗∗
History of hyperglycemia (yes vs no) 1.17 0.51–2.68
BMI=body mass index, CI= confidence interval, FINDRISK= Finnish Diabetes Risk Score, OGTT= oral glucose tolerance test, OR= odds ratio, SD= standard deviation, TC= total cholesterol, TG= triglyceride,
WC=waist circumference.
∗
P= .002.
∗∗
P= .007.
∗∗∗
P= .048.
∗∗∗∗
P= .046.
† Participating in >8 sessions.
Table 1
Baseline characteristic of people enrolled in the study according to participation in the intervention.
Completed interventions (n=184) Did not complete interventions (n=74)
Variable Mean SD Mean SD P value
Age 55.9 11.1 54.9 12.2 .386
Body mass index, kg/m2 31.8 4.9 32.6 4.6 .157
Waist circumference, cm 98.8 11.8 100.9 9.2 .062
Systolic blood pressure, mm Hg 131.9 14.3 134.5 14.1 .798
Diastolic blood pressure, mm Hg 81.9 8.4 83.6 10.3 .446
Fasting glucose, mmol/L 5.3 0.7 5.4 0.7 .686
2-H OGTT glucose, mmol/L 5.8 1.8 6.6 2.1 .046
TC, mmol/L 5.5 1.0 5.8 1.3 .098
HDL cholesterol, mmol/L 1.4 0.4 1.4 0.4 .906
TG, mmol/L 1.7 1.2 2.4 2.6 .004
FINDRISK 18.3 2.8 18.7 2.9 .629
% %
Men 22 30 .136
Education
Basic/medium 79 72 .193
High 21 28
Married/having a partner/cohabiting (yes vs no) 70 72 .468
Employed (yes vs no) 39 54 .037
Current smoking (yes vs no) 20 26 .179
History of hyperglycaemia (yes vs no) 60 55 .487
History of hypertension (yes vs no) 65 77 .043
History of depression (yes vs no) 16 16 .574
Family history of diabetes (yes vs no) 58 70 .066
>30-minute daily physical activity (yes vs no) 16 19 .368
Daily consumption of vegetables and fruit (yes vs no) 41 30 .055
FINDRISK= Finnish Diabetes Risk Score, HDL=high-density lipoprotein, IFG= impaired fasting glucose, IGT= impaired glucose tolerance, OGTT=oral glucose tolerance test, SD= standard deviation, TC= total
cholesterol, TG= triglyceride.
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medications and consumed little fruit and vegetables were
significantly less likely to take up the programme.[18] Low
participation in the prevention programmes is observed even
among patients with much higher DM2 risk like, for example, in
the DM2 prevention trial among women with gestational
diabetes.[19] In this study, recruitment was more challenging
than anticipated with only 89 out of 410 (22%) women agreeing
to participate in the programme.[19] In our study, employment
was an independent factor decreasing the likelihood of
participation 2 times. This is in concordance with the Health
Improvement and Prevention Study (HIPS), where mixed and
complex method to assess the factors influencing attendance was
used.[17] In this study, people who were older, did not work, and
had higher levels of psychological distress were significantly more
likely to attend. Working commitments and problems with
accessing the programme were described as important
obstacles.[17] Attendance was promoted by providing sessions
outside working hours. Similarly to our study, in the HIPS, the
lifestyle modification programme was taken up mainly by
nonworking participants.[17] Also, as reported by Gucciardi
et al, conflict with working hours schedule could be the main
obstacle in an uptake of DM2 education services.[21] In Finland,
in the prevention study among airline company employees, the
uptake of the group intervention was so low that group
intervention was discontinued.[6] Instead, a diabetes prevention
website was created, with good uptake measured as the number
of visits per year.[6] In another DPS implementation study run in
Finland—FIN-D2D—project with similar uptake of the pro-
gramme being unemployed and undereducated was related to
active participation in the intervention but only in men.[9] In the
Greek DE-PLAN study, recruitment through workplace was the
most successful strategy in identifying high-risk individuals,
enrolling, and maintaining them in the study.[11] Therefore, to
improve the reach and attendance of working people it seems
essential to develop strategies targeted towards providing
convenient and accessible services. In fact, several new strategies
are being investigated like for instance internet-based interven-
tions, telephone counseling, mobile apps, or workplace-run
interventions.[22–28]
Inour study, similarly to the SydneyDPPhealthier behaviors like
more frequent consumption of vegetables and fruit was observed
among completers. In baseline characteristics people who
participated in the study also had a better health profile; higher
1200 OGTT glucose was an independent factor decreasing the
chance to participate in the intervention. These findings might
point out to a higher awareness and motivation among people
participating in lifestyle intervention studies and are concordant
with previous studies where people participating in epidemiologi-
cal studies had a healthier profile than general population.[7,8,29,30]
This is also in line with some other studies, where participation in
the RCTs was high, which suggests that people participating in
intervention studies are a very selective and highly motivated
group.[2] Inour study alsopeoplewithhypertensionwere less likely
to complete the intervention. This association, also present in the
SydneyDPP, is not clear butmight be in linewith observations that
people with a worse health profile are less likely to participate in
prevention initiatives.[18]
In our study, there were no particular socioeconomic differ-
ences between completers and noncompleters but in previously
published research low socioeconomic status was related to less
frequent use of health care services despite poorer health
status.[30,31] Our findings underline the need of further research
to improve the completion of the prevention programmes among
high-risk individuals. The lack of association between age and
completion of the intervention might result from the narrow age
range for this study and small sample size.
Some strengths and limitations of our study need to be
discussed. This is one of the first real-life, real-setting studies
investigating factors influencing completion of diabetes preven-
tion lifestyle intervention among high diabetes risk individuals
without diabetes. The participants in our study were volunteers,
and, similarly to many other studies, this one predominantly
attracted women. Around 22% out of those who completed the
study were men, while among noncompleters the percentage of
men was 30%. Very low uptake of the intervention by men
suggests that the results of the study might not be generalized to
both sexes and implies the need for further studies on sex-specific
mechanism of completion of real-life lifestyle interventions. There
are also important psychological factors influencing completion
and attrition rates in lifestyle prevention programmes which were
not studied in our project which further implies the need for
continued investigation separately for both sexes.[9,31,32] We
should also interpret lifestyle data with caution as the measure of
vegetables and fruit consumption frequency and physical activity
was very crude.
Furthermore, there are very important practical barriers like
work commitments, accessibility, affordability, and practicality
of the interventions[17–19] as well as factors related to the quality
of intervention given by GPs and prevention officers which were
not investigated in our study and, as indicated by other research,
might be very important in diabetes prevention programme
uptake.[17,18] In our study, some of noncompleters reported also
other than working commitments like “taking care of children,”
“taking care of grandchildren,” or “taking care of elderly
parents” as the reason of the drop out. However, the total
number of people who gave any reason of nonparticipation in the
intervention was low.
These observations highlight the need to develop lifestyle
interventions further in order to increase completion of the
programmes by males, particularly those who are working and
those at high risk. Results and experience of the DE-PLAN
programme were used in the preparation of the European
guidelines and the toolkit for the Diabetes Prevention in Europe
where some strategies for the reach of focus population have
been described.[33,34] The study is being continued in the city of
Krakow as a self-government-sponsored initiative.
In conclusion, further insight into the determinants of
completion of real-life diabetes type 2 prevention interventions
is needed to learn about the barriers as well as to improve the
reach and attendance of target population.
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